Aptys Pharmaservices, a subsidiary of Aptys Pharmaceuticals, has specialized as an expert CRO in galenic formulation, analytical development and quality control in a Good Manufacturing Practices (GMP) environment.<\/p>\n
With its ability to innovate and solve formulation problems, Aptys Pharamaservices now offers two innovative approaches to solving the solubility and bioavailability problems of active ingredients.<\/p>\n
Many biotech and pharmaceutical companies are facing problems of solubility of their candidate molecules. It is a problem in terms of their bioavailability, which could be summarized as the molecule\u2019s ability to reach its pharmacological target.<\/p>\n
Also, in the early stage of development, companies have small quantities of product, preventing the establishment of conventional protocols.<\/p>\n
To address this double problem, Aptys Pharmaservices offers two technologies, Soludiag and Nanosolution.<\/p>\n
Soludiag is a fast, sequenced and low-matter-consuming solution. It makes it possible to evaluate the solubility of the molecule in about twenty conditions of solvents and co-solvents compatible with a pre-clinical and clinical use but also to find conditions to formulate these molecules and make them more bioavailable.<\/p>\n
Nanosolution is a technique that optimizes the conditions for particle size reduction, thus increasing the bioavailability of insoluble molecules. Nanosolution has the advantage of being able to test many compositions in a single step and using little material.<\/p>\n
<\/p>\n